These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17256805)

  • 21. [Clinical experimental research in hematology: planning, data management and the presentation of the results].
    Kulikov SM; Savchenko VG; Maslova ER; Parovichnikova EN; Gudulina IuIu
    Ter Arkh; 1996; 68(7):65-72. PubMed ID: 8928076
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnosing model diagnostics.
    Karlsson MO; Savic RM
    Clin Pharmacol Ther; 2007 Jul; 82(1):17-20. PubMed ID: 17571070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When less is more: using shrinkage to increase accuracy.
    Wears RL; Normand SL
    Ann Emerg Med; 2010 Jun; 55(6):553-5. PubMed ID: 20494223
    [No Abstract]   [Full Text] [Related]  

  • 24. Discussion of the paper "Adaptive dose-ranging designs".
    Burman CF
    J Biopharm Stat; 2007; 17(6):1005-11; discussion 1029-32. PubMed ID: 18027210
    [No Abstract]   [Full Text] [Related]  

  • 25. How much do we have to pay for how many interim analyses?
    Koch A
    Contemp Clin Trials; 2005 Feb; 26(1):113-6. PubMed ID: 15837456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statistics review 9: one-way analysis of variance.
    Bewick V; Cheek L; Ball J
    Crit Care; 2004 Apr; 8(2):130-6. PubMed ID: 15025774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How much statistics do we need?
    Bacharova L
    J Electrocardiol; 2007 Jan; 40(1):110-1. PubMed ID: 16916520
    [No Abstract]   [Full Text] [Related]  

  • 28. Interpreting and reporting clinical trials with results of borderline significance.
    Hackshaw A; Kirkwood A
    BMJ; 2011 Jul; 343():d3340. PubMed ID: 21727163
    [No Abstract]   [Full Text] [Related]  

  • 29. Cautionary tales in the clinical interpretation of studies of diagnostic tests.
    Scott IA; Greenberg PB; Poole PJ
    Intern Med J; 2008 Feb; 38(2):120-9. PubMed ID: 17645501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weighted nonparametric maximum likelihood estimate of a mixing distribution in nonrandomized clinical trials.
    Liu C; Xie J; Zhang Y
    Stat Med; 2007 Dec; 26(29):5303-19. PubMed ID: 17497612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discussion of the "White Paper of the PhRMA Working Group on adaptive dose-ranging designs".
    Grieve AP
    J Biopharm Stat; 2007; 17(6):997-1004; discussion 1029-32. PubMed ID: 18027209
    [No Abstract]   [Full Text] [Related]  

  • 32. Combining proof-of-concept with dose-finding: utilization of adaptive designs in migraine clinical trials.
    Sagkriotis A; Scholpp J
    Cephalalgia; 2008 Aug; 28(8):805-12. PubMed ID: 18513264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What should be the role of homogeneity testing in adaptive trials?
    Gallo P; Chuang-Stein C
    Pharm Stat; 2009; 8(1):1-4. PubMed ID: 18642402
    [No Abstract]   [Full Text] [Related]  

  • 34. A defence of rigorous method in clinical science.
    Malone-Lee J
    Neurourol Urodyn; 2008; 27(6):462-5. PubMed ID: 18508330
    [No Abstract]   [Full Text] [Related]  

  • 35. [Tricks, devices, expedients and stratagems in the management and interpretation of cardiological trials].
    Frea S; Bobbio M
    G Ital Cardiol (Rome); 2006 Nov; 7(11):761-7. PubMed ID: 17216918
    [No Abstract]   [Full Text] [Related]  

  • 36. The need to address uncertainty and heterogeneity of treatment effect in clinical studies.
    Daniel Mullins C
    Clin Ther; 2010 Feb; 32(2):274. PubMed ID: 20206785
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of the simulation in the clinical investigation].
    Monleón-Getino T
    Med Clin (Barc); 2013 Dec; 141(12):550-5. PubMed ID: 24238627
    [No Abstract]   [Full Text] [Related]  

  • 38. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trials with allergen products--statistical considerations.
    Volkers P
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):172-80; discussion 181. PubMed ID: 17393737
    [No Abstract]   [Full Text] [Related]  

  • 40. [How to improve the quality of clinical trials].
    Galende I; Sacristán JA; Soto J
    Med Clin (Barc); 1994 Apr; 102(12):465-70. PubMed ID: 8207997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.